Amarenco Raises 300 Million Euros to Support Its Growth as a Solar IPP and Storage Energy Player

Amarenco, a Franco-Irish company specialising in photovoltaic energy, has just completed a new round of capital raising for 300 m€. This latest round allows Arjun Infrastructure Partners, to acquire a minority stake in Amarenco. Arjun Infrastructure joins, alongside a pool of investors from the Crédit Agricole Group, Tikehau Capital, an alternative asset management group, which has made a significant contribution to Amarenco's growth since 2020.

Why this third round of financing 3 years after the first?

With uninterrupted growth every year since its creation, Amarenco Group has the capacity, thanks to this third round of capital raising, to take another important step towards achieving its objectives; In particular, in terms of ecosystem regeneration, by initiating, for example, the first micro-forest and soil regeneration projects (to produce regenerative energy) in 2023, or by successfully implementing energy storage systems such as the flagship 100 megawatt-hour "Claudia" project.

More generally, this new round of financing will make it possible to fund the company's development ambitions over the coming months/years:

  • Converting its multi-GW projects into assets across all of its geographies over the next 3 years
  • Continue to expand across all of its 3 strategic pillars, i.e. solar, energy storage and agripv infrastructures, with a particular focus on corporate offtakers by supporting them in achieving their net carbon ambitions and long term power price hedging strategies across their sites all their geographies.

As part of this fundraising, Julian Skinner and Romain Py from Arjun Infrastructure join Amarenco's board of directors, which also includes Mathieu Badjeck and Pierrre Abadie, co-heads of Tikehau Capital's Private Equity Energy Transition practice.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.